Yu‐Shui Ma

4.5k citations
117 papers · 3.0k indexed · 1 hit paper · h-index 31

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • Circular RNAs in diseases
    • RNA modifications and cancer
    • Extracellular vesicles in disease
    • Epigenetics and DNA Methylation
    • Ubiquitin and proteasome pathways

Papers in

    • MicroRNA in disease regulation 36
    • Cancer-related molecular mechanisms research 32
    • Circular RNAs in diseases 27
    • RNA modifications and cancer 20
    • Ubiquitin and proteasome pathways 9

Yu‐Shui Ma

116 papers receiving 3.0k citations

Hit Papers

Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring 2022 · 269 citations
269202220262023202450100150200250

Peers

Yu‐Shui Ma
Comparison fields: 5 of 131
  • Cancer Research 1.3k
  • Molecular Biology 1.9k
  • Oncology 619
  • Immunology 332
  • Hepatology 115
Replace Xuetian Yue with:
Xuetian Yue China
Guido T. Bommer Belgium
Christina Warnecke Germany
Yan‐Wei Hu China
Marie C. Lin China
Yun‐Yong Park South Korea
Min Feng China
Sankar Addya United States
Benjamin D. Hopkins United States
Yu‐Shui Ma relative to Xuetian Yue China Xuetian Yue's profile →
Citations per field
00.5×1.5×1.9×
Xuetian Yue · 1×
Citations per year

Countries citing papers authored by Yu‐Shui Ma

Since Specialization
Citations

This map shows the geographic impact of Yu‐Shui Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Shui Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Shui Ma more than expected).

Fields of papers citing papers by Yu‐Shui Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Shui Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Shui Ma. The network helps show where Yu‐Shui Ma may publish in the future.

Co-authors

The 25 scholars most cited alongside Yu‐Shui Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yu‐Shui Ma Line = papers co-authored together Yu‐Shui Ma links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 202312
3 202242
4 202115
5 202112
6 202124
7 20214
8 20218
9 202031
10 202026
11 20193
12 201835
13 201826
14 201718
15 201719
16 20148
17 201115
18 201167
19 201159
20 201198

About Yu‐Shui Ma

Yu‐Shui Ma is a scholar working on Cancer Research, Molecular Biology, Oncology, Aging and Pathology and Forensic Medicine, having authored 117 papers that have together received 3.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (36 papers), Cancer-related molecular mechanisms research (32 papers), Circular RNAs in diseases (27 papers), RNA modifications and cancer (20 papers), Ubiquitin and proteasome pathways (9 papers), Ferroptosis and cancer prognosis (7 papers), Cancer Cells and Metastasis (7 papers) and Cancer Mechanisms and Therapy (7 papers). The work is most often cited by research in Cancer Research (1.3k citations), Molecular Biology (1.9k citations), Oncology (619 citations), Immunology (332 citations) and Hepatology (115 citations). Yu‐Shui Ma has collaborated with scholars based in China, United States and Tanzania. Frequent co-authors include Da Fu, Xizhong Shen, Jibin Liu, Wen Li, Ying Fang, Yi Shi, Ji‐Bin Liu, Chengyou Jia, Shengdi Wu and Gai‐Xia Lu. Their work appears in journals such as PLoS ONE, Molecular Therapy — Oncolytics, Technology in Cancer Research & Treatment, Molecular Therapy — Nucleic Acids and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026